HOME › DRUGS › ABALOPARATIDE
ACTIVE SUBSTANCE / INN

ABALOPARATIDE

Brand name(s): TYMLOS, Eladynos
FDA LISTED
EMA LISTED
PRESCRIPTION
REFUSED
AUTHORISED
Osteoporosis, Postmenopausal;Osteoporosis
Osteoporosis
ACTIVE SUBSTANCE
Abaloparatide
REGULATORS
FDA · EMA
SPONSORS / MAH
RADIUS, Radius Health Ireland Ltd, Theramex Ireland Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TYMLOSNDA208743RADIUSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EladynosTheramex Ireland LimitedAuthorised12/12/2022Osteoporosis, Postmenopausal;Osteoporosis
EladynosRadius Health Ireland LtdRefusedOsteoporosis

FULL INTELLIGENCE ON ABALOPARATIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →